Today's Clinical Trials...Tomorrow's Treatment

Presenter: Dr. Glenn Bauman
Original Date: Tuesday, March 28, 2017

Description:

Here are the learning objectives for this webinar:
  1. To understand the importance of clinical trials in improving care for men with prostate cancer
  2. To understand the different types of clinical trials
  3. Review examples of important trials that have influenced care for men with prostate cancer
  4. Review challenges and new directions for clinical trials

Dr. Glenn Bauman's Biography:

Dr. Bauman is a Radiation Oncologist specializing in Genitourinary and Central Nervous System Malignancies. He is also the Professor and Chair/Chief of the Department of Oncology at the Schulich School of Medicine and Dentistry, University of Western Ontario in London, Ontario and is an Associate Scientist, Lawson Health Research Institute.  Dr. Bauman received both his undergraduate and medical degrees from the University of Western Ontario, where he also completed his residency in Radiation Oncology. A clinical fellowship in Radiation Oncology in the area of adult and pediatric brain tumor treatment was completed at the University of California at San Francisco. Dr. Bauman’s primary areas of clinical practice are in genitourinary and central nervous system tumors and areas of research interest are multi-modality image guided radiotherapy and cancer imaging.

About Expert Angle

Expert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

   




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More

Prostate Cancer Canada announces new President and CEO

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada.
More

Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More


Click here for news archive